AllSight
Companies · PRME · Biological Products, (No Diagnostic Substances)
Prime Medicine, Inc. (PRME)
Prime Medicine, Inc. (PRME) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Aug 6, 2026
Clinical pipeline advances, but cash fell sharply and revenue missed expectations
Related companies in Biological Products, (No Diagnostic Substances)
About AllSight · Editorial standards & method · Contact